Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 622

1.

Contributions of weekly mean blood glucose values to hemoglobin A1c in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).

Murata GH, Hoffman RM, Duckworth WC, Wendel CS, Shah JH; Diabetes Outcomes in Veterans Study.

Am J Med Sci. 2004 Jun;327(6):319-23.

PMID:
15201644
[PubMed - indexed for MEDLINE]
2.

Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).

Murata GH, Shah JH, Hoffman RM, Wendel CS, Adam KD, Solvas PA, Bokhari SU, Duckworth WC; Diabetes Outcomes in Veterans Study (DOVES).

Diabetes Care. 2003 Jun;26(6):1759-63.

PMID:
12766106
[PubMed - indexed for MEDLINE]
3.

Evaluating once- and twice-daily self-monitored blood glucose testing strategies for stable insulin-treated patients with type 2 diabetes : the diabetes outcomes in veterans study.

Hoffman RM, Shah JH, Wendel CS, Duckworth WC, Adam KD, Bokhari SU, Dalton C, Murata GH; Diabetes Outcome in Veterans Study.

Diabetes Care. 2002 Oct;25(10):1744-8.

PMID:
12351471
[PubMed - indexed for MEDLINE]
4.

Factors affecting hypoglycemia awareness in insulin-treated type 2 diabetes: The Diabetes Outcomes in Veterans Study (DOVES).

Murata GH, Duckworth WC, Shah JH, Wendel CS, Hoffman RM; Diabetes Outcomes in Veterans Study.

Diabetes Res Clin Pract. 2004 Jul;65(1):61-7.

PMID:
15163479
[PubMed - indexed for MEDLINE]
5.
6.

Risk factor management in stable, insulin-treated patients with Type 2 diabetes: the Diabetes Outcomes in Veterans Study.

Murata GH, Shah JH, Wendel CS, Hoffman RM, Adam KD, Bokhari SU, Solvas PA, Duckworth WC.

J Diabetes Complications. 2003 Jul-Aug;17(4):186-91.

PMID:
12810241
[PubMed - indexed for MEDLINE]
7.

Sources of glucose variability in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).

Murata GH, Duckworth WC, Shah JH, Wendel CS, Hoffman RM.

Clin Endocrinol (Oxf). 2004 Apr;60(4):451-6.

PMID:
15049959
[PubMed - indexed for MEDLINE]
8.

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.

Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG; GWAA Study Group.

Ann Intern Med. 2005 Oct 18;143(8):559-69.

PMID:
16230722
[PubMed - indexed for MEDLINE]
10.

Continued use of an integrated meter with electronic logbook maintains improvements in glycemic control beyond a randomized, controlled trial.

Laffel LM, Hsu WC, McGill JB, Meneghini L, Volkening LK.

Diabetes Technol Ther. 2007 Jun;9(3):254-64.

PMID:
17561796
[PubMed - indexed for MEDLINE]
11.

A comparison of fructosamine and HbA1c for home self-monitoring blood glucose levels in type 2 diabetes.

Chen HS, Chen RL, Chang ZY, Li HD.

Zhonghua Yi Xue Za Zhi (Taipei). 2002 Apr;65(4):151-5.

PMID:
12135193
[PubMed - indexed for MEDLINE]
12.

A probabilistic model for predicting hypoglycemia in type 2 diabetes mellitus: The Diabetes Outcomes in Veterans Study (DOVES).

Murata GH, Hoffman RM, Shah JH, Wendel CS, Duckworth WC.

Arch Intern Med. 2004 Jul 12;164(13):1445-50.

PMID:
15249354
[PubMed - indexed for MEDLINE]
13.

Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry.

Karter AJ, Ackerson LM, Darbinian JA, D'Agostino RB Jr, Ferrara A, Liu J, Selby JV.

Am J Med. 2001 Jul;111(1):1-9.

PMID:
11448654
[PubMed - indexed for MEDLINE]
14.

Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.

Abraira C, Duckworth W, McCarren M, Emanuele N, Arca D, Reda D, Henderson W; VA Cooperative Study of Glycemic Control and Complications in Diabetes Mellitus Type 2.

J Diabetes Complications. 2003 Nov-Dec;17(6):314-22.

PMID:
14583175
[PubMed - indexed for MEDLINE]
15.

Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group.

Saudek CD, Duckworth WC, Giobbie-Hurder A, Henderson WG, Henry RR, Kelley DE, Edelman SV, Zieve FJ, Adler RA, Anderson JW, Anderson RJ, Hamilton BP, Donner TW, Kirkman MS, Morgan NA.

JAMA. 1996 Oct 23-30;276(16):1322-7.

PMID:
8861991
[PubMed - indexed for MEDLINE]
16.

Comparison of continuous blood glucose measurement with conventional documentation of hypoglycemia in patients with Type 2 diabetes on multiple daily insulin injection therapy.

Zick R, Petersen B, Richter M, Haug C; SAFIR Study Group.

Diabetes Technol Ther. 2007 Dec;9(6):483-92.

PMID:
18034602
[PubMed - indexed for MEDLINE]
17.
18.

Using continuous glucose monitoring to measure the frequency of low glucose values when using biphasic insulin aspart 30 compared with biphasic human insulin 30: a double-blind crossover study in individuals with type 2 diabetes.

McNally PG, Dean JD, Morris AD, Wilkinson PD, Compion G, Heller SR.

Diabetes Care. 2007 May;30(5):1044-8. Epub 2007 Feb 2.

PMID:
17277042
[PubMed - indexed for MEDLINE]
19.

HbA1c levels are better predicted by prebreakfast than postbreakfast blood glucose self-analyses in type 2 diabetes. Influence of duration of diabetes and mode of treatment.

Relimpio F, Guerrero R, Martínez-Brocca MA.

Acta Diabetol. 2007 Jun;44(2):55-9. Epub 2007 May 27.

PMID:
17530467
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk